Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Systemic Lignocaine for Postoperative Pain in Open Abdominal Surgeries
NCT01699919Phase 4Completed
- Sponsor
- JIPMER
- Start
- Apr 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, postoperative ileus (POI) and postoperative nausea and vomiting (PONV) (2 arms), sponsored by JIPMER. Primary endpoint: Postoperative pain scores using visual analogue scale at 24 hours. Started Apr 2011; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painpostoperative ileus (POI)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01699919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01699919.